1. Home
  2. LND vs LXEO Comparison

LND vs LXEO Comparison

Compare LND & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

LND

Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

HOLD

Current Price

$3.74

Market Cap

355.6M

ML Signal

HOLD

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

HOLD

Current Price

$4.67

Market Cap

396.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LND
LXEO
Founded
2005
2017
Country
Brazil
United States
Employees
457
N/A
Industry
Farming/Seeds/Milling
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
355.6M
396.5M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
LND
LXEO
Price
$3.74
$4.67
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$18.44
AVG Volume (30 Days)
42.0K
1.0M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
3.18%
N/A
EPS Growth
N/A
39.81
EPS
N/A
N/A
Revenue
N/A
$654,000.00
Revenue This Year
$1.65
N/A
Revenue Next Year
$6.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.46
$3.91
52 Week High
$4.45
$10.99

Technical Indicators

Market Signals
Indicator
LND
LXEO
Relative Strength Index (RSI) 51.36 47.48
Support Level $3.67 $4.30
Resistance Level $3.81 $5.36
Average True Range (ATR) 0.10 0.35
MACD 0.01 0.01
Stochastic Oscillator 50.00 26.02

Price Performance

Historical Comparison
LND
LXEO

About LND Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

Brasilagro - Cia Bras de Prop Agricolas is a Brazil-based company, engaged in the acquisition, development, operation, and sale of rural properties suitable for agricultural activities. The business activity of the firm is operated through Real estate, Grains, Sugarcane, Cattle rising, Cotton, and Other segments. The Grains segment is involved in the production and sale of soybean and corn. The Sugarcane segment includes the sale of raw product. The Real Estate segment presents the P&L from operations carried out in the company's subsidiaries. The Cattle Raising segment consists of producing and selling beef calves after weaning, which characterizes the activity as breeding and the Other segment engages in other corporate activities. The majority of revenue is earned from Grain Segment.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.

Share on Social Networks: